The Exchange has sought clarification from Shilpa Medicare Limited with respect to announcement dated 11-Aug-2022 informing about Appointment.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Brief profile (in case of appointment) 2. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority The response of the company is awaited.
Kothari Products Limited has informed the Exchange about press release dated 12-Aug-2022 titled UNAUDITED (STANDALONE & CONSOLDIATED) FINANCIAL RESULTS - 30.06.2022 PUBLSIHED IN NEWSPAPERS
Navkar Corporation Limited has informed the Exchange about Notice of Annual General Meeting to be held on 07-Sep-2022
We enclose a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company, for Vasopressin Injection USP.
MAXHEALTH : The Exchange has sought clarification from Max Healthcare Institute Limited with respect to recent news item captioned 27% Stake In Max Healthcare Put On Block Amid KKR Exit Reports. The response from the Company is awaited.
NGL Fine-Chem Limited has informed the Exchange about resignation of K V SUBRAMANIAN as Independent Director of the company w.e.f. 10-Aug-2022
Tci Finance Limited has informed the Exchange about press release dated 13-Aug-2022 titled Results of quarter ended June, 2022
Brightcom Group Limited has informed the Exchange about press release dated 16-Aug-2022 titled Brightcom Group achieves strong first quarter results for FY23
The Exchange had sought clarification from Tera Software Limited with respect to announcement dated 12-08-2022 regarding Outcome of Board Meeting.On the basis of aforesaid disclosure, the Listed entity was required to clarify the following:Change in directors, key managerial personnel (Managing Director, Chief Executive Officer, Chief Financial Officer, Company Secretary etc.), Auditor and Compliance Officer:1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authorityThe response of the company is attached.
The Exchange had sought clarification from Hexa Tradex Limited with respect to announcement dated 10-08-2022 regarding Appointment.On the basis of aforesaid disclosure, the Listed entity was required to clarify the following:Change in directors, key managerial personnel (Managing Director, Chief Executive Officer, Chief Financial Officer, Company Secretary etc.), Auditor and Compliance Officer:1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authorityThe response of the company is attached.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
